C12N2740/11011 - CPC Classification Index

ClassID:

110287 ⎘

C12N2740/11011 - CPC Classification

Classification description:

Reverse transcribing RNA viruses; Details; Retroviridae Alpharetrovirus, e.g. avian leucosis virus

Sub-classes:

C12N2740/11021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 0
C12N2740/11022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 11
C12N2740/11023 » Virus like particles [VLP] 8
C12N2740/11031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
C12N2740/11032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 0
C12N2740/11033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 0
C12N2740/11034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 4
C12N2740/11041 » Use of virus, viral particle or viral elements as a vector 0
C12N2740/11051 » Methods of production or purification of viral material 5
C12N2740/11061 » Methods of inactivation or attenuation 0
C12N2740/11071 » Demonstrated in vivo effect 0
C12N2740/11088 » For redistribution 0

Recent Application in this class:

20130034564

Anti-RSV G protein antibodies

20110008770

COMPOSITIONS AND METHODS FOR REVERSE TRANSCRIPTION OF NUCLEIC ACID MOLECULES

20110008332

Combination Therapy to Treat Persistent Viral Infections

20100285022

Anti-RSV G protein antibodies

20090130120

Anti-RSV G protein antibodies

20070269878

COMPOSITIONS AND METHODS FOR REVERSE TRANSCRIPTION OF NUCLEIC ACID MOLECULES